Venture Capital Archives - Page 93 of 99

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

THIS WEEK'S STORIES

Redwire Chief Scientist Dr. Kenneth Savin Named to TIME100 Health List for Pioneering Space-Based Biotech Research

May 8, 2025

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Pioneer Institute Tool Finds Drug Price Controls Raising Costs for Many Medicare Patients

May 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Jaanuu Acquired by VentureOn Management in Strategic Asset Sale

HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Therapies for Chronic and Age-Related Diseases

TSOLife Raises $43 Million Series B to Advance AI-Driven Innovation in Senior Living Communities

GeneDx Completes Acquisition of Fabric Genomics to Expand Global Genomic Medicine Capabilities

Koala Health Raises $20 Million in Series B to Expand Pet Medication Delivery Platform

Most Read

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Aera Therapeutics Names Paul Conrad as Chief Business and Financial Officer

Marana Health Partners with athenahealth to Enhance Whole-Person Care and Streamline Patient Experience

Pioneer Institute Tool Finds Drug Price Controls Raising Costs for Many Medicare Patients

EDITOR PICKS

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

THIS WEEK'S STORIES

Redwire Chief Scientist Dr. Kenneth Savin Named to TIME100 Health List for Pioneering Space-Based Biotech Research

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Pioneer Institute Tool Finds Drug Price Controls Raising Costs for Many Medicare Patients

POPULAR CATEGORY

ABOUT US

FOLLOW US